COVID-19 vaccination in rheumatology patients: What experts say
Patients on rituximab might need to postpone or delay therapy, they suggest
UK experts have proposed evidence-based management strategies for rheumatology patients on immunosuppressive therapy, including delaying or postponing rituximab, as appropriate.
In a commentary in Rheumatology, Dr Paul Emery of the University of Leeds and colleagues outline data on the effect of antirheumatic therapy on vaccine responses in patients with inflammatory arthritis.
